Ginsenosides as Anticancer Agents: In vitro and in vivo Activities, Structure-Activity Relationships, and Molecular Mechanisms of Action.
about
Review on Bifidobacterium bifidum BGN4: Functionality and Nutraceutical Applications as a Probiotic MicroorganismNeutral sphingomyelinase 2 modulates cytotoxic effects of protopanaxadiol on different human cancer cells.Characterization, Molecular Docking, and In Vitro Dissolution Studies of Solid Dispersions of 20(S)-Protopanaxadiol.Ginsenoside compound K induces apoptosis in nasopharyngeal carcinoma cells via activation of apoptosis-inducing factor.Ginseng and anticancer drug combination to improve cancer chemotherapy: a critical review.The interaction of serum albumin with ginsenoside Rh2 resulted in the downregulation of ginsenoside Rh2 cytotoxicity.Panax ginseng total protein promotes proliferation and secretion of collagen in NIH/3T3 cells by activating extracellular signal-related kinase pathway.Ginsenoside 20(S)-Rg3 targets HIF-1α to block hypoxia-induced epithelial-mesenchymal transition in ovarian cancer cells.Yin and Yang of ginseng pharmacology: ginsenosides vs gintonin.The use of dietary supplements to alleviate androgen deprivation therapy side effects during prostate cancer treatmentGinsenoside‑Rg5 induces apoptosis and DNA damage in human cervical cancer cellsMatrix metalloproteinase-13 downregulation and potential cartilage protective action of the Korean Red Ginseng preparation.Ginsenoside Rg-1 protects retinal pigment epithelium (RPE) cells from cobalt chloride (CoCl2) and hypoxia assaults.Anticancer Activity of Saponins from Allium chinense against the B16 Melanoma and 4T1 Breast Carcinoma Cell.MALDI imaging for the localization of saponins in root tissues and rapid differentiation of three Panax herbs.Ginseng consumption and risk of cancer: A meta-analysis.Molecular dynamic simulation insights into the normal state and restoration of p53 function.Oral nano-delivery of anticancer ginsenoside 25-OCH3-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti-prostate cancer activity, and mechanisms of action.Involvement of Wnt/β-catenin signaling in the mesenchymal stem cells promote metastatic growth and chemoresistance of cholangiocarcinoma.Enzymatic formation of compound-K from ginsenoside Rb1 by enzyme preparation from cultured mycelia of Armillaria mellea.The antitumor activity study of ginsenosides and metabolites in lung cancer cell.Anticancer compounds from plants.Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils.Development and Validation of a Rapid and Simple UPLC-ESI-MS Method for Pharmacokinetics and Tissue Distribution of Astragaloside III in RatsThe growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safetyProcessed Vietnamese ginseng: Preliminary results in chemistry and biological activity.The toxicity and pathology of selected dietary herbal medicines.Bioengineering of plant (tri)terpenoids: from metabolic engineering of plants to synthetic biology in vivo and in vitro.FOLFOX 4 combined with herbal medicine for advanced colorectal cancer: a systematic review.The amphiphilic nature of saponins and their effects on artificial and biological membranes and potential consequences for red blood and cancer cells.Antitumor effects of traditional Chinese medicine targeting the cellular apoptotic pathway.Ginsenoside Rg1 prevents starvation-induced muscle protein degradation via regulation of AKT/mTOR/FoxO signaling in C2C12 myotubesNatural Compounds As Modulators of Non-apoptotic Cell Death in Cancer Cells.Clinacanthus Nutans Hexane Extracts Induce Apoptosis Through a Caspase-Dependent Pathway in Human Cancer Cell LinesCellular stress response mechanisms as therapeutic targets of ginsenosides.Effects of Panax ginseng extracts prepared at different steaming times on thermogenesis in rats.In silico studies for the interaction of tumor necrosis factor-alpha (TNF-α) with different saponins from Vietnamese ginseng (Panax vietnamesis).Ginsenoside Rb1 inhibits hypoxia-induced epithelial-mesenchymal transition in ovarian cancer cells by regulating microRNA-2520(S)-Rg3 blocked epithelial-mesenchymal transition through DNMT3A/miR-145/FSCN1 in ovarian cancerGinsenoside-Rb1 targets chemotherapy-resistant ovarian cancer stem cells via simultaneous inhibition of Wnt/β-catenin signaling and epithelial-to-mesenchymal transition.
P2860
Q28068567-6DA624B2-FE7A-4391-9F88-52816BB5AAA5Q31124060-7CDD9C1B-75BC-4C71-9116-88A8A76A4866Q31162573-6DBA9FF3-6891-40E5-B7BF-F8EC2FC366BBQ33614100-834155FE-BD49-4DB1-A604-B987FBE6D251Q33614591-1AC1010E-556E-496C-B923-93314DFDC056Q33850000-9FE01CA5-FFDA-4524-876B-8DD68AFB198EQ33850008-EFBB8B88-E7C0-4D85-A1AD-3749399E0620Q34149627-C44D0BCF-1D2E-4C18-B3F5-7AE5A8D8B2C3Q34377467-EDC4EECA-CA7A-4BA2-B059-EA6E0030635EQ34411758-699351AD-6AEC-4CD3-8AE3-B474BC71DBA3Q34673643-EC823606-E8C3-40A9-BF29-15D05CA941A5Q34719220-391D153C-93BA-413D-A83E-7F2589225CDFQ35080838-2ADEB975-4DF0-42AD-BDA5-78DCE20C37E9Q35749385-FCD34092-5183-4876-B5EC-18A971054BDEQ35962207-3FDFBCBA-3B02-4A18-97D4-585A19EFDD24Q36129616-8FB97EAC-DB29-443D-AC08-683AC4FB1B9EQ36202281-832F55E7-CF6F-4B6C-802E-26147F4BE966Q36356343-4D00D923-9BA0-4B09-9E53-D5D904C2E3CDQ36561746-2A75D687-5740-4E71-8D19-18110025CB14Q36835741-1A5009F0-93F7-4F92-9B92-EF33A8215C08Q36879558-1D641F9A-16D6-4CC6-80F7-E49CDEBEB5B2Q36920695-5A03AEDE-66A8-4323-A5B2-4475AA31175AQ36941956-73F77FEE-141D-4D4A-BF83-6BB76DD818A7Q36960543-F3194976-7873-4E9F-A427-D699A69757F7Q37459724-F822FBBB-CDFE-472D-AD0D-43D96E8B88D1Q37702656-4E405CC1-D4D4-42CA-AB9D-85658F7FB2B5Q38069420-291A873C-D582-4DC6-A833-54878ABE7123Q38106149-1CE80D18-F912-4800-AC6B-1D19DBA4775BQ38171776-EBBBF04E-5962-4082-B55E-5612148C12CFQ38258125-C85F4634-E2DA-4E50-AEB6-E717F1438CA7Q38521666-412384A0-A2A0-4F72-AC3E-6005544B4850Q38638011-A02AA5B4-48B5-434F-B3A7-310EF1106052Q39214221-06C26155-1892-4659-A590-C0782F6DE758Q39301295-FD41D795-BF74-4517-926A-52C72B99223BQ39354303-FDE584EC-715D-4FE9-9908-744B51335455Q41009825-0C9018B9-F32D-4FC8-ADEF-8502DBC31D22Q41227150-32CC7ECA-D183-43BF-9429-EBDD411A2E9DQ41530251-C5564E9B-EDB2-43E9-86F4-17BD1E723456Q41593179-0290A879-B1D3-4A4E-9C3F-2337392289D9Q42265763-1433A5B7-569A-4995-AD8E-7AA320BE519C
P2860
Ginsenosides as Anticancer Agents: In vitro and in vivo Activities, Structure-Activity Relationships, and Molecular Mechanisms of Action.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Ginsenosides as Anticancer Age ...... olecular Mechanisms of Action.
@ast
Ginsenosides as Anticancer Age ...... olecular Mechanisms of Action.
@en
type
label
Ginsenosides as Anticancer Age ...... olecular Mechanisms of Action.
@ast
Ginsenosides as Anticancer Age ...... olecular Mechanisms of Action.
@en
prefLabel
Ginsenosides as Anticancer Age ...... olecular Mechanisms of Action.
@ast
Ginsenosides as Anticancer Age ...... olecular Mechanisms of Action.
@en
P2093
P2860
P356
P1476
Ginsenosides as Anticancer Age ...... olecular Mechanisms of Action.
@en
P2093
Jiang-Jiang Qin
Ming-Hai Wang
Subhasree Ashok Nag
P2860
P356
10.3389/FPHAR.2012.00025
P577
2012-02-28T00:00:00Z